Seprase as a marker for cancer

Details for Australian Patent Application No. 2008335855 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Roessler, Markus; Karl, Johann; Rollinger, Wolfgang; Kochan, Jarema Peter; Tacke, Michael

Agent Davies Collison Cave

Pub. Number AU-B-2008335855

PCT Pub. Number WO2009/074275

Priority 07023897.7 10.12.07 EP; 08015310.9 29.08.08 EP

Filing date 8 December 2008

Wipo publication date 18 June 2009

Acceptance publication date 30 August 2012

International Classifications

G01N 33/574 Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

6 May 2010 PCT application entered the National Phase

  PCT publication WO2009/074275 Priority application(s): WO2009/074275

30 August 2012 Application Accepted

  Published as AU-B-2008335855

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008335879-Apparatus and process for forming profiles with a variable height by means of cold rolling

2008335840-Treatment of melanoma with alpha thymosin peptides in combination with antibodies against cytotoxic T lymphocyte-associated antigen 4 (CTLA4)